Web Analytics

3 Latest Announced Rounds

  • $80,000,000
    Series C

    2 Investors

    IT Services and IT Consulting
    Sep 27th, 2024
  • $2,143,528
    Seed

    1 Investors

    Computer & Network Security
    Sep 27th, 2024
  • $12,000,000
    Pre-Seed

    2 Investors

    Research Services
    Sep 27th, 2024
$1,390.46M Raised in 84 Funding Rounds in the past 7 Days - View All

Funding Round Profile

VitaDAO

start up
  • 15/02/2023
  • Unknown
  • $4,100,000

VitaDAO is a community owned collective funding early stage longevity research
We discover and fund the most promising longevity research. We are funding early stage research, and try to turn it into biotech companies. Members can join VitaDAO by purchasing VITA tokens or earning them through contributions of work or Intellectual Property.


Related People

Tyler GolatoFounder

Tyler Golato Germany - Berlin, Berlin

I am currently Co-Founder and Chief Scientific Officer at Molecule GmbH, a platform to facilitate decentralised, modular, and collaborative drug development. I am also a founding steward at VitaDAO, a decentralised funding collective focused on longevity research. I previously completed an IRTA Fellowship at the National Institute on Aging (NIH/NIA/IRP) in the Laboratory of Molecular Gerontology under Dr. David M. Wilson III and Dr. Vilhelm Bohr where my work was concerned with the repair of endogenous DNA damage, specifically in the context of ageing. As an undergraduate, I worked with Dr. Ron Hutchison and Dr. Daniel Hernandez investigating pathogenesis in limulus egg populations using Next-Generation Sequencing (NGS). Additionally, I worked in the laboratory of Dr. Robert Fine at Columbia University investigating mechanisms of chemotherapy resistance in pancreatic cancer and working to develop novel therapeutic strategies for various cancers.